SCHEMBL10029595

SCHEMBL10029595

C=C1NC(=O)C(C(C)C)=C1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14298095 0.79
SCHEMBL12851540 0.70 TOP2A (0.31)
SCHEMBL13613085 0.70
Isobutane SCHEMBL526680 0.67
SCHEMBL841001 0.65 KDM4E (0.32)
SCHEMBL18960133 0.65
SCHEMBL13884888 0.65
Isobutane SCHEMBL5703421 0.65 TOP2A (0.31)
SCHEMBL19626639 0.62
SCHEMBL9346004 0.62 TSHR (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9642869-B2 Boronic acid derivatives and therapeutic uses thereof REMPEX PHARMACEUTICALS, INC. (US) 2017-05-09 US disclosed
US-20120077854-A1 COMPOSITIONS AND METHODS FOR MODULATING RETINOL BINDING TO RETINOL BINDING PROTEIN 4 (RBP4) IRM LLC (BM) 2012-03-29 US disclosed